Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 1999

View Archived Issues

Crescendo submits two NDAs to FDA during Q3 1999

MGI Pharma makes significant progress with MGI-114 development during third quarter

Protease inhibitors for HCV infection developed at Vertex

Trademark verdict disputed by Pfizer

CDC advisory committee recommends Wyeth-Lederle's pneumococcal conjugate vaccine for routine use

Sheffield Pharmaceuticals completes inhaled steroid agreement with Elan

FP receptor agonists claimed by Procter & Gamble for bone disorders, glaucoma

New antitumor diterpenes discovered in China

Chinese researchers isolate new immunosuppressive fungal metabolite

PTPase inhibitors in early development at Novo Nordisk

Novel oncological compounds acting as antagonists of protein-carbohydrate binding

Merck's new GH secretagogues described in recent patent

Polyamine derivatives designed at U. of Florida for reduced toxicity

Patents cover Immtech's lead dicationic antifungal agents

Immtech receives patent coverage for rmCRP in platelet disorders

Agouron to commercialize Rescriptor throughout the world; anti-HIV pipeline grows

Development of OvaRex is now sole focus for AltaRex

Pharmacia & Upjohn reviews recent FDA developments for its products

Recent steps taken toward creation of Aventis

Antiepileptic potential of EPC-K1 demonstrated in rat model

LMW heparin to be marketed in U.K. and Ireland by ICN

First approval obtained for bivalirudin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...